Culture Biosciences develops automated bioreactor infrastructures and runs it as a service for biotech companies.

Visit Website
Year of Investment
2020
Investors
Jeff Fluhr
Bryan Rosenblatt
Exit
Investment Type
Series A
Category
Enterprise